We have provided evidence that treatment with the p21 peptide (Warbrick, 2000), capable of binding the PCNA interdomain connecting loop, reversed the delay in apoptosis observed in neutrophils from CF patients and restored apoptosis levels to that of healthy controls (Martin et al., 2016b). Here, CDKN1A is linked to cystic fibrosis.